GlassScriptPhysician profile
Stephanie Cooper
NPI 1811249147
$1,983.11
in general payments reported to CMS, 2019-2025
17 companies · $294 in 2025
The $294 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2020: $215 · 2021: $341 · 2022: $364 · 2023: $188 · 2024: $348 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $630 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $629.59 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $398.33 | 2020-2023 | |
| Alcon Vision LLC | $366.76 | 2019-2025 | Tryptyr, Total30 |
| Mallinckrodt Hospital Products INC. | $249.25 | 2023-2025 | Acthar |
| Shire North American Group INC | $149.28 | 2019 | |
| Glaukos Corporation | $145.77 | 2020-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $139.19 | 2023-2025 | Tecnis Iol, Tecnis Simplicity |
| Allergan, INC. | $122.81 | 2022 | |
| Bausch & Lomb Americas INC. | $99.68 | 2023 | Miebo |
| Aerie Pharmaceuticals, INC. | $57.67 | 2019-2020 | |
| Coopervision INC. | $51.40 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $46.49 | 2024 | Xdemvy |
| Kala Pharmaceuticals, INC. | $37.16 | 2021 | |
| Sun Pharmaceutical Industries INC. | $29.64 | 2024 | |
| Astellas Pharma US INC | $27.50 | 2024 | Izervay |
| Rayner Intraocular Lenses Limited | $24.50 | 2025 | Rayner Cataract Set 1, Rayone Aspheric, Rayone Emv |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $22.52 | 2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Johnson & Johnson Vision Care, INC. | $15.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.